These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10355150)

  • 21. [High-dose inhaled beclomethasone in long-term management of chronic severe asthma--usefulness and dose-dependence].
    Kudo K; Tanabe N; Kabe J
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 May; 34(5):536-44. PubMed ID: 8753111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids.
    Woolcock A; Lundback B; Ringdal N; Jacques LA
    Am J Respir Crit Care Med; 1996 May; 153(5):1481-8. PubMed ID: 8630590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma].
    Ukena D; Harnest U; Sakalauskas R; Magyar P; Vetter N; Steffen H; Leichtl S; Rathgeb F; Keller A; Steinijans VW
    Pneumologie; 1998 Jul; 52(7):377-84. PubMed ID: 9738388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic equivalence study of two formulations (innovator v. generic) of beclomethasone dipropionate in adult asthmatic patients.
    Nell H; Louw CM; Cyster H; Williams Z; Bardin PG; Joubert JR
    S Afr Med J; 2001 Jan; 91(1):51-6. PubMed ID: 11236299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma.
    Papi A; Canonica GW; Maestrelli P; Paggiaro P; Olivieri D; Pozzi E; Crimi N; Vignola AM; Morelli P; Nicolini G; Fabbri LM;
    N Engl J Med; 2007 May; 356(20):2040-52. PubMed ID: 17507703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group.
    Laviolette M; Malmstrom K; Lu S; Chervinsky P; Pujet JC; Peszek I; Zhang J; Reiss TF
    Am J Respir Crit Care Med; 1999 Dec; 160(6):1862-8. PubMed ID: 10588598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma.
    Barnes NC; Pujet JC
    Thorax; 1997 Jun; 52(6):523-7. PubMed ID: 9227718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extrafine beclomethasone dipropionate breath-actuated inhaler (400 micrograms/day) versus budesonide dry powder inhaler (800 micrograms/day) in asthma.
    Reichel W; Dahl R; Ringdal N; Zetterstrom O; van den Elshout FJ; Laitinen LA
    Int J Clin Pract; 2001 Mar; 55(2):100-6. PubMed ID: 11321849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inhaled beclomethasone in long-term management of asthma: optimal dose and optimal duration of treatment].
    Kudo K; Hojo M; Kabe J
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Sep; 33(9):956-65. PubMed ID: 8538091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Churg-Strauss syndrome after reduction of inhaled corticosteroid in a patient treated with pranlukast for asthma.
    Hashimoto M; Fujishima T; Tanaka H; Kon H; Saikai T; Suzuki A; Nakatsugawa M; Abe S
    Intern Med; 2001 May; 40(5):432-4. PubMed ID: 11393418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lung function and asthma control with beclomethasone and formoterol in a single inhaler.
    Huchon G; Magnussen H; Chuchalin A; Dymek L; Gonod FB; Bousquet J
    Respir Med; 2009 Jan; 103(1):41-9. PubMed ID: 18977646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of dosing schedule on efficacy of corticosteroid inhalation in chronic asthma].
    Suzuki R; Taki F; Taniguchi H; Kondoh Y; Tanaka H; Watanabe Y; Suzuki K; Ogawa K; Torii K; Takagi K
    Arerugi; 1995 Jul; 44(7):685-91. PubMed ID: 7575134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical effects of pranlukast, an oral leukotriene receptor antagonist, in mild-to-moderate asthma: a 4 week randomized multicentre controlled trial.
    Yoo SH; Park SH; Song JS; Kang KH; Park CS; Yoo JH; Choi BW; Hahn MH;
    Respirology; 2001 Mar; 6(1):15-21. PubMed ID: 11264758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of inhaled corticosteroid combined with theophylline and double-dose inhaled corticosteroid in moderate to severe asthma.
    Wang Y; Wang CZ; Lin KX; Qian GS; Zhuo WL; Li SP; Zhao ZQ; Liao XQ; Song YX
    Respirology; 2005 Mar; 10(2):189-95. PubMed ID: 15823184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids.
    Crompton GK; Ayres JG; Basran G; Schiraldi G; Brusasco V; Eivindson A; Jamieson AH; Olsson H
    Am J Respir Crit Care Med; 1999 Mar; 159(3):824-8. PubMed ID: 10051257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Duration of the effect of inhaled corticosteroids on lung function and sensitivity of the respiratory tract in patients with bronchial asthma].
    Magnussen H; Willenbrock U; Jörres R
    Med Klin (Munich); 1995 Apr; 90(4):214-9. PubMed ID: 7776933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of cysteinyl leukotrienes in the pathogenesis of asthma: clinical study of leukotriene antagonist pranlukast for 1 year in moderate and severe asthma.
    Kohrogi H; Iwagoe H; Fujii K; Hamamoto J; Fukuda K; Hirata N; Kawano O; Matsumoto M; Suga M; Ando M
    Respirology; 1999 Sep; 4(3):319-23. PubMed ID: 10489683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of switching low-dose inhaled corticosteroid to pranlukast for step-down therapy in well-controlled patients with mild persistent asthma.
    Harada S; Harada N; Itoigawa Y; Katsura Y; Kasuga F; Ishimori A; Makino F; Ito J; Atsuta R; Takahashi K
    J Asthma; 2016; 53(2):207-12. PubMed ID: 26325232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular mechanism of the additive effects of leukotriene modifier in asthmatic patients receiving steroid therapy.
    Matsunaga K; Yanagisawa S; Ichikawa T; Akamatsu K; Koarai A; Hirano T; Sugiura H; Minakata Y; Ichinose M
    Allergol Int; 2009 Mar; 58(1):89-96. PubMed ID: 19153534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.